Potential clinical applications of this study and specifically of MeTC7 reside in the small-molecule immunotherapy of AML, ovarian cancer, and pancreatic cancer, the cell lines of which show vitamin D/VDR dependencies of PD-L1 expressions. The gene discussed is VDR; the disease is acute myeloid leukemia.